Nabsys 2.0, LLC (Nabsys or the Company), a pioneer in electronic genome mapping (EGM) technology, today announced the appointment of Alka Chaubey, Ph.D., FACMG, as Chief Medical and Genomics Officer, effective July 6, 2026. In this role, Dr. Chaubey will lead the Company's medical and scientific affairs strategy, strengthen collaborations with researchers and key opinion leaders, and help expand the adoption and application of EGM across research and translational medicine.